Empowering Tomorrow’s Great Minds in Cancer Research: The Parker Institute for Cancer Immunotherapy Awards up to $4.5 Million to Nine Early Career Researchers; Total of Over $19 Million Awarded to Date

Scientists chosen in four categories, including new Representation In SciencE (RISE) Scholar award focused on furthering diversity, equity, inclusion and belonging in the scientific community SAN FRANCISCO–(BUSINESS WIRE)–#Biotech—The Parker Institute for Cancer Immunotherapy (PICI) is helping to forge a future without cancer, by investing in today’s top talent to train and empower the research leaders … [Read more…]

Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022

New ticker symbol (Nasdaq: QNCX) to initiate trading on August 1, 2022 SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–$CRTX–Cortexyme, Inc. (Nasdaq: CRTX) today announced that the company’s planned corporate name change to Quince Therapeutics is expected take effect on Monday, August 1, 2022. In conjunction with the corporate name change, the company plans to issue a news … [Read more…]

Alnylam Uncovers Genetic Mutations in INHBE That Protect Against Abdominal Obesity

– Publication in Nature Communications Reports that People with Loss of Function Mutations in the INHBE Gene Have Reduced Abdominal Fat, a Favorable Metabolic Profile, and are at Lower Risk of Cardiovascular Disease and Type 2 Diabetes – – Alnylam to Pursue INHBE as a Therapeutic Target for Cardiometabolic Disease – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, … [Read more…]

Surescripts Transforms Patient Access to Specialty Drugs, Optimizing Adherence

Increased Provider Access to Real-Time Patient Information Means Greater Efficiency, Enhanced Safety and Lower Costs ARLINGTON, Va.–(BUSINESS WIRE)–#HealthIT–More prescribers and specialty pharmacists nationwide are adopting Surescripts Specialty Medications solutions to transform the manual process used to prescribe specialty medications, saving time and money for patients and providers. In May 2022, the number of prescribers enabled … [Read more…]

Cue Health to Announce Second Quarter 2022 Financial Results

SAN DIEGO–(BUSINESS WIRE)–Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its second quarter 2022 financial results on Wednesday, August 10, 2022. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to … [Read more…]

The Institute for Functional Medicine Once Again Receives Accreditation with Commendation by the Accreditation Council for Continuing Medical Education

IFM is the leading voice for functional medicine and advancing the transformation of health care for patients and practitioners worldwide. FEDERAL WAY, Wash.–(BUSINESS WIRE)–The Institute for Functional Medicine (IFM) is proud to announce their recent Accreditation with Commendation, awarded by the Accreditation Council for Continuing Medical Education (ACCME). IFM has been continuously accredited by the … [Read more…]

Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies

VANCOUVER, British Columbia & SAN FRANCISCO–(BUSINESS WIRE)–$ABCL—AbCellera (Nasdaq: ABCL) and Versant Ventures today announced a multi-year collaboration to discover therapeutic antibodies for multiple targets selected by Versant’s portfolio of biologics-focused biotechs. Versant and AbCellera already have enabled three of the firm’s stealth-stage companies under previous partnerships. Under the terms of the deal, Versant portfolio companies … [Read more…]

OneSpaWorld Announces Second Quarter Fiscal 2022 Financial Results on August 3, 2022

NEW YORK–(BUSINESS WIRE)–OneSpaWorld Holdings Limited, (NASDAQ: OSW), the pre-eminent global provider of health and wellness products and services on board cruise ships and in destination resorts around the world, announced today that it will release its Second Quarter Fiscal 2022 earnings on Wednesday, August 3rd before market open. The Company will conduct a conference call … [Read more…]

908 Devices to Participate in the Canaccord Genuity 42nd Annual Growth Conference

BOSTON–(BUSINESS WIRE)–908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will be participating in the upcoming Canaccord Genuity 42nd Annual Growth Conference. 908 Devices’ management is scheduled to host a Fireside Chat on Wednesday, August 10th at 2:00 p.m. Eastern Time. … [Read more…]

Rocket Pharmaceuticals Appoints Mayo Pujols as Chief Technical Officer and Strengthens Manufacturing Capabilities

— Mayo Pujols brings nearly three decades of technical operations and manufacturing experience, of which the past five years have been exclusively focused on cell and gene therapy, from leading biopharma companies including Andelyn Biosciences, Novartis and Celgene— — Mr. Pujols will lead technical operations and the Company’s state-of-the-art, recently cGMP ready, Clinical and potential … [Read more…]